Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewNeuroscienceTherapeutics Open Access | 10.1172/JCI164792

A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models

Susumu Ikenoshita,1 Kazuya Matsuo,1 Yasushi Yabuki,1 Kosuke Kawakubo,1 Sefan Asamitsu,1 Karin Hori,1 Shingo Usuki,2 Yuki Hirose,3 Toshikazu Bando,3 Kimi Araki,4 Mitsuharu Ueda,5 Hiroshi Sugiyama,3 and Norifumi Shioda1

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Ikenoshita, S. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Matsuo, K. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Yabuki, Y. in: JCI | PubMed | Google Scholar

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Kawakubo, K. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Asamitsu, S. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Hori, K. in: JCI | PubMed | Google Scholar

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Usuki, S. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Hirose, Y. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Bando, T. in: JCI | PubMed | Google Scholar

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Araki, K. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Ueda, M. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Sugiyama, H. in: JCI | PubMed | Google Scholar |

1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan

2Liaison Laboratory Research Promotion Center, Kumamoto University, Kumamoto, Japan

3Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan

4Division of Developmental Genetics, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

5Department of Neurology, Kumamoto University, Kumamoto, Japan

Find articles by Shioda, N. in: JCI | PubMed | Google Scholar |

Published September 14, 2023 - More info

J Clin Invest. https://doi.org/10.1172/JCI164792.
Copyright © 2023, Ikenoshita et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published September 14, 2023 - Version history
View PDF
Abstract

Expansion of CAG and CTG (CWG) triplet repeats causes several inherited neurological diseases. The CWG repeat diseases are thought to involve complex pathogenic mechanisms through expanded CWG repeat-derived RNAs in a non-coding and polypeptides in a coding region, respectively. However, an effective therapeutic approach has not been established for the CWG repeat diseases. Here, we show that a CWG repeat DNA-targeting compound, cyclic pyrrole¬–imidazole polyamide (CWG-cPIP), suppresses the pathogenesis of coding and non-coding CWG repeat diseases. CWG-cPIP binds to the hairpin form of mismatched CWG DNA, interfering with transcription elongation by RNA polymerase through a preferential activity towards repeat-expanded DNA. We found that CWG-cPIP selectively inhibits pathogenic mRNA transcripts from expanded CWG repeats, reducing CUG RNA foci and polyglutamine accumulation in cells from patients with myotonic dystrophy type-1 (DM1) and Huntington’s disease (HD). Treatment with CWG-cPIP ameliorated behavioral deficits in adeno-associated virus-mediated CWG repeat-expressing mice and a genetic mouse model of HD, without cytotoxicity or off-target effects. Together, we present a novel candidate compound that targets expanded CWG repeat DNA independent of its genomic location and reduces both pathogenic RNA and protein levels. CWG-cPIP may be used for the treatment of CWG repeat diseases and for improving clinical outcomes.

Supplemental material

View

View Supplementary File 1

View Supplementary File 2

View Supplementary File 3

View Supplementary File 4

View Supplementary File 5

View Supplementary File 6

Version history
  • Version 1 (September 14, 2023): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts